Abstract
This chapter reviews the history of migraine headaches and development of the first headache classification. The most current international classification of headache disorders is reviewed with the main focus being around those headache types that frequently represent therapeutic challenges. Key symptoms that may guide the practitioner in the diagnostic process of these headache conditions are discussed with special attention devoted to the medically resistant headaches. This chapter will discuss diagnostic challenges and commonly suggested diagnostic criteria that should be helpful in deciding when it should be appropriate to refer patient to a headache specialist and when to apply an interventional treatment strategy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clifford FR. The history of migraine from Mesopotamian to Medieval times. Cephalalgia. 1995;15 Suppl 15:1–3.
Adams F. The extant works of Aretaeus, the Cappadocian. London: New Sydenham Society; 1856.
Critchley M. Migraine: from Cappadocia to queen square. In: Smith R, editor. Background to migraine. London: Heinemann; 1967. p. 16–21.
Kuehn CG. Claudii Galeni opera omnia, vol. 12. Leipzig: Officina Car. Cnoblochii; 1826.
Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia. 2004;24 Supp 1:9–160.
Tfelt-Hansen PC, Koehler PJ. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia. 2008;28(8):877–86.
Schulman EA, Lake 3rd AE, Goadsby PJ, Peterlin B, Siegel S, Markley HG, et al. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache. 2008;48(6):778–82.
Schulman EA, Brahin EJ. Refractory headache: historical perspective, need, and purposes for an operational definition. Headache. 2008;48(6):770–7.
Silberstein S, Dodick D, Pearlman S. Defining the pharmacological intractable headache for clinical trials and clinical practice. Headache. 2010;50:1499–506.
Kruit MC, Launer LJ, Overbosch J, van Buchem MA, Ferrari MD. Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia. 2009;29(3):351–9.
Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience. 2001;106(4):793–800.
Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007;47(10):1418–26.
Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127(Pt 1):220–30.
Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache. 1987;27(8):416–20.
Wang W, Schoenen J. Interictal potentiation of passive “oddball” auditory event-related potentials in migraine. Cephalalgia. 1998;18(5):261–5.
Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87(3):543–52.
Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371–7.
Tournier-Lasserve E. Hemiplegic migraine, episodic ataxia type 2, and the others. Neurology. 1999;53:3–4.
Feoktistov A, Filatova E, Vein A. Abuse headache. Zh Nevrol Psikhiatr Im S S Korsakova. 1999;12:58–61.
Warner J. Frequent migraine and migraine status without tension-type headaches: an unusual presentation of rebound headaches. Cephalalgia. 2003;23(4):309–13.
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26(6):742–6.
Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814–23.
Feoktistov A. Clinico-psychophysiological peculiarities of the patients with abuse headache. Monograph (dissertation for Ph.D. degree), Ministry of Public Health of Russian Federation, Moscow Medical Academy, Moscow; 2001. p. 1–168.
Feoktistov A, Filatova E, Vein A. Psychophysiological characteristic of groups of patients with analgesic rebound headache. Zh Nevrol Psikhiatr Im S S Korsakova. 2002;10:13–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Feoktistov, A. (2014). Headache Classifications and Medically Resistant Headaches. In: N. Narouze, S. (eds) Interventional Management of Head and Face Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8951-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8951-1_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8950-4
Online ISBN: 978-1-4614-8951-1
eBook Packages: MedicineMedicine (R0)